No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

Lung cancer remains the most frequently diagnosed cancer globally, with 2.5 million new cases, representing 12.4% of all ...

Cadonilimab is included for the treatment of relapsed or metastatic cervical cancer (R/M CC) patients who progressed on or after platinum-based chemotherapy. Ivonescimab is included for the treatment ...

focusing on key genes linked to non-small cell lung cancer (NSCLC). Advt The study found that adenocarcinoma was the most ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...

A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.